MC1878A1 - Compositions pharmaceutiques - Google Patents

Compositions pharmaceutiques

Info

Publication number
MC1878A1
MC1878A1 MC871918A MC1918A MC1878A1 MC 1878 A1 MC1878 A1 MC 1878A1 MC 871918 A MC871918 A MC 871918A MC 1918 A MC1918 A MC 1918A MC 1878 A1 MC1878 A1 MC 1878A1
Authority
MC
Monaco
Prior art keywords
pharmaceutical compositions
pharmaceutical
compositions
Prior art date
Application number
MC871918A
Other languages
English (en)
French (fr)
Inventor
Rai Behl Charanjit
Unowsky Joeel
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of MC1878A1 publication Critical patent/MC1878A1/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/28Steroids, e.g. cholesterol, bile acids or glycyrrhetinic acid

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
MC871918A 1986-10-07 1987-10-06 Compositions pharmaceutiques MC1878A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US91615086A 1986-10-07 1986-10-07

Publications (1)

Publication Number Publication Date
MC1878A1 true MC1878A1 (fr) 1989-01-24

Family

ID=25436780

Family Applications (1)

Application Number Title Priority Date Filing Date
MC871918A MC1878A1 (fr) 1986-10-07 1987-10-06 Compositions pharmaceutiques

Country Status (14)

Country Link
EP (1) EP0263493A3 (xx)
JP (1) JPS6396138A (xx)
CN (1) CN87106855A (xx)
AU (1) AU7939487A (xx)
DK (1) DK521487A (xx)
FI (1) FI874382A (xx)
HU (1) HU196903B (xx)
IE (1) IE872667L (xx)
IL (1) IL84099A0 (xx)
MC (1) MC1878A1 (xx)
NO (1) NO874193L (xx)
PT (1) PT85871B (xx)
ZA (1) ZA876930B (xx)
ZW (1) ZW18787A1 (xx)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0643315B2 (ja) * 1988-01-20 1994-06-08 東京田辺製薬株式会社 胆汁酸組成物
DD293494A5 (de) * 1989-03-29 1991-09-05 Fahlberg List Gmbh Magdeburg Verfahren zur herstellung einer galenischen zubereitung mit optimaler bioverfuegbarkeit des wirkstoffs 2-hydroxy-5-methyllauro-phenonoxim (hmlo)
CA2033714A1 (en) * 1990-01-25 1991-07-26 Alberto Ferro Pharmaceutical preparations
US5534261A (en) * 1995-01-17 1996-07-09 University Of Southern California Retinoid-based compositions and method for preventing adhesion formation using the same
US8088734B2 (en) 2003-01-21 2012-01-03 Unigene Laboratories Inc. Oral delivery of peptides
US8093207B2 (en) * 2005-12-09 2012-01-10 Unigene Laboratories, Inc. Fast-acting oral peptide pharmaceutical products
CN102316889B (zh) 2008-11-26 2014-11-26 萨蒂奥根制药公司 组合物及使用方法
CA2744817C (en) 2008-11-26 2020-07-07 Satiogen Pharmaceuticals, Inc. Bile acid recycling inhibitors for treatment of obesity and diabetes
EP3593802A3 (en) 2010-05-26 2020-03-25 Satiogen Pharmaceuticals, Inc. Bile acid recycling inhibitors and satiogens for treatment of diabetes, obesity, and inflammatory gastrointestinal conditions
PL2771003T3 (pl) 2011-10-28 2017-10-31 Lumena Pharmaceuticals Llc Inhibitory ponownego wykorzystania kwasów żółciowych do leczenia pediatrycznych cholestatycznych chorób wątroby
CN105617353A (zh) * 2016-01-04 2016-06-01 李志海 一种黏菌素口服给药组合物

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5562007A (en) * 1978-11-02 1980-05-10 Fujisawa Pharmaceut Co Ltd Preparation for rectal administration
JPS57158719A (en) * 1981-03-24 1982-09-30 Fujisawa Pharmaceut Co Ltd Rectal administration pharmaceutical
US4760059A (en) * 1985-08-05 1988-07-26 Hoffmann-La Roche Inc. Rectal dosage form

Also Published As

Publication number Publication date
NO874193D0 (no) 1987-10-06
CN87106855A (zh) 1988-04-20
ZA876930B (en) 1988-05-25
EP0263493A3 (de) 1989-06-14
ZW18787A1 (en) 1988-05-25
FI874382A (fi) 1988-04-08
PT85871A (en) 1987-11-01
AU7939487A (en) 1988-04-14
IE872667L (en) 1988-04-07
EP0263493A2 (de) 1988-04-13
JPS6396138A (ja) 1988-04-27
HUT45395A (en) 1988-07-28
NO874193L (no) 1988-04-08
HU196903B (en) 1989-02-28
DK521487D0 (da) 1987-10-05
FI874382A0 (fi) 1987-10-06
DK521487A (da) 1988-04-08
PT85871B (en) 1990-01-17
IL84099A0 (en) 1988-03-31

Similar Documents

Publication Publication Date Title
FR2636532B1 (fr) Compositions pharmaceutiques
SE8801813L (sv) Pharmaceutical composition
FR2547727B1 (fr) Compositions pharmaceutiques
KR890701101A (ko) 제약학적 조성물
DK89090D0 (da) Farmaceutisk praeparat
DK705488A (da) Farmaceutisk praeparat
FI872733A0 (fi) Farmaceutiska kompositioner.
FI872313A0 (fi) Farmaceutiska kompositioner.
MC1878A1 (fr) Compositions pharmaceutiques
MX172943B (es) Formulacion farmaceutica
DK142487D0 (da) Farmaceutiske midler
DK139388D0 (da) Farmaceutisk praeparat
MX11584A (es) Composiciones farmaceuticas
IT1216814B (it) Composizioni farmaceutiche
FR2618676B1 (fr) Compositions pharmaceutiques antivirales
IT1203737B (it) Composizioni farmaceutiche comprendenti 3-amminopropossi-indoli
DE3768109D1 (de) Pharmazeutische zusammensetzungen.
IT1224244B (it) Composizione farmaceutica anoressizzante comprendente 5-idrossitrpofano
DK138888D0 (da) Farmaceutisk praeparat
DK428287D0 (da) Nasalt farmaceutisk praeparat
SE8700576D0 (sv) Pharmaceutical composition
SE8705100D0 (sv) Farmaceutisk komposition
IT8619483A0 (it) Composizioni farmaceutiche.
LV5734B4 (lv) Farmaceitiskas kompozicijas
LV5728A4 (lv) Farmaceitiskas kompozicijas

Legal Events

Date Code Title Description
YP Annual fee paid